Cerebral infarction complicating intravenous immunoglobulin therapy in a patient with Miller Fisher syndrome

Journal of Neurology Neurosurgery and Psychiatry

Volumn 68, Issue 6, 2000, Pages 790-791

  Turner, Benjamin ^a   Wills, Adrian J ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Cerebral infarction; Intravenous immunoglobulin; Miller Fisher syndrome

Indexed keywords

GANGLIOSIDE ANTIBODY; IMMUNOGLOBULIN;

ADULT; ARTICLE; BRAIN INFARCTION; CAMPYLOBACTER JEJUNI; CASE REPORT; CEREBRAL BLINDNESS; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; PRIORITY JOURNAL; SUBCLAVIAN STEAL SYNDROME;

EID: 0034021528     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.68.6.790     Document Type: Article

References (8)

1. Hughes RAC. Intravenous IgG in Guillain-Barré syndrome. BMJ 1996;313:376-77.
2. Ropper AH. Miller Fisher syndrome and other acute variants of Guillain-Barré syndrome. In: Mcleod JG, ed. Inflammatory neuropathies. London: Baillière's Clinical Neurology 1994;95-106.
3. Yuki N, Taki T, Takahashi M, et al. Molecular mimicry between GQIb ganglioside and liposaccharides of Campylobacter jejuni isolated from patients with Fishers syndrome. Ann Neurol 1994;36:791-3.
4. Ledeen RW, Wu G. Ganglioside function in the neuron. Trends in Glycoscience and Glycotechnology 1992;4:174-87.
5. Plomp JJ, Molenaar PC, O'Hanlon GM, et al. Miller-Fisher anti-GQ1b antibodies: α-latrotoxin-like effects on motor end plates. Ann Neurol 1999;45:189-99.
6. Gill G, Leese G. Hyponatraemia: biochemical and clinical perspectives. Postgrad Med J 1998;74:516-23.
7. Wills AJ, Unsworth DJ. A practical approach to the use of intravenous immunoglobulin in neurological disease. Eur Neurol 1998;39:3-8.
8. Stangel M, Hartung HP, Marx P, et al. Intravenous immunoglobulin treatment of neurological autoimmune diseases. J Neurol Sci 1998;153:203-14.